Lingli Yang Selected Research

Therapeutics

1/2021	Ginsenoside Rb1 exerts antidepressant-like effects via suppression inflammation and activation of AKT pathway.
12/2020	Local Epidermal Endocrine Estrogen Protects Human Melanocytes against Oxidative Stress, a Novel Insight into Vitiligo Pathology.
1/2016	Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
7/2015	Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.
8/2014	Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract-induced atopic dermatitis in NC/Nga mice.
7/2014	Periostin accelerates human malignant melanoma progression by modifying the melanoma microenvironment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lingli Yang Research Topics

Disease

10	Vitiligo 02/2024 - 03/2012
3	Stroke (Strokes) 01/2024 - 05/2010
3	Melanoma (Melanoma, Malignant) 10/2021 - 07/2014
2	Neoplasms (Cancer) 10/2021 - 07/2015
2	Inflammation (Inflammations) 01/2021 - 01/2016
2	Tuberous Sclerosis (Bourneville's Disease) 02/2018 - 07/2015
2	Hypopigmentation (Hypomelanosis) 02/2018 - 01/2018
2	Ischemic Stroke 09/2017 - 05/2011
2	Dermatitis 01/2016 - 08/2014
2	Sclerosis 01/2015 - 01/2012
2	Atopic Dermatitis (Atopic Eczema) 08/2014 - 08/2014
1	Acne Vulgaris 03/2024
1	Pleural Effusion (Pleural Effusions) 08/2022
1	Esophageal Neoplasms (Esophageal Cancer) 08/2022
1	Intrahepatic Cholestasis 05/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Dehydration (Water Stress) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Neoplasm Metastasis (Metastasis) 10/2021
1	COVID-19 01/2021
1	Pathologic Constriction (Stenosis) 09/2017
1	Hypertension (High Blood Pressure) 09/2017
1	Dyslipidemias (Dyslipidemia) 09/2017
1	Type 2 Diabetes Mellitus (MODY) 09/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Major Depressive Disorder (Major Depressive Disorders) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Infections 01/2016
1	Irritant Dermatitis 01/2016
1	Body Weight (Weight, Body) 11/2015
1	Angiofibroma 07/2015
1	Mixed Connective Tissue Disease (MCTD) 02/2015
1	Prurigo 08/2014
1	Eczema 08/2014
1	Skin Diseases (Skin Disease) 08/2014
1	Disease Progression 07/2014

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2020 - 05/2010
5	PeriostinIBA 01/2015 - 01/2012
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 05/2011
3	rhododendrolIBA 10/2021 - 03/2015
3	Sirolimus (Rapamycin)FDA Link 02/2018 - 08/2014
2	Serotonin (5 Hydroxytryptamine)IBA 01/2024 - 11/2015
2	IgA receptor (protein B)IBA 10/2021 - 09/2021
2	Glycoproteins (Glycoprotein)IBA 10/2021 - 09/2021
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 11/2015
2	AutoantibodiesIBA 01/2019 - 02/2015
2	TOR Serine-Threonine KinasesIBA 02/2018 - 07/2015
2	trans-sodium crocetinate (crocetin)IBA 02/2018 - 07/2015
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017 - 11/2015
2	Histamine (Histamine Dihydrochloride)FDA Link 08/2014 - 02/2014
2	IntegrinsIBA 07/2014 - 05/2012
1	SaponinsIBA 03/2024
1	16S Ribosomal RNAIBA 02/2024
1	Therapeutic UsesIBA 05/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	8- (4- carboxymethyloxy)phenyl- 1,3- dipropylxanthineIBA 01/2022
1	Abscisic AcidIBA 01/2022
1	SaltsIBA 01/2022
1	Neuroprotective AgentsIBA 11/2021
1	sanqiIBA 11/2021
1	Endothelin-1 (Endothelin 1)IBA 09/2021
1	Stem Cell FactorIBA 09/2021
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Triclosan (pHisoHex)FDA Link 01/2021
1	ginsenoside Rb1IBA 01/2021
1	Estrogens (Estrogen)FDA Link 12/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	CreatinineIBA 09/2017
1	Uric Acid (Urate)IBA 09/2017
1	Urea (Carbamide)FDA LinkGeneric 09/2017
1	Cystatin CIBA 09/2017
1	C-Reactive ProteinIBA 09/2017
1	OxazoloneIBA 01/2016
1	GlucocorticoidsIBA 01/2016
1	Oxidoreductases (Dehydrogenase)IBA 01/2016
1	Picryl Chloride (Trinitrochlorobenzene)IBA 01/2016
1	11-dehydrocorticosteroneIBA 01/2016
1	CorticosteroneIBA 01/2016
1	VaccinesIBA 01/2016
1	HaptensIBA 01/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2015
1	Imipramine (Janimine)FDA LinkGeneric 11/2015
1	Dopamine (Intropin)FDA LinkGeneric 11/2015
1	Melanins (Melanin)IBA 03/2015
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 02/2015
1	Vitamin D FDA LinkGeneric 01/2015
1	AntigensIBA 08/2014
1	Ointments (Pastes)IBA 08/2014
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 08/2014
1	CollagenIBA 08/2014
1	Extracellular Matrix ProteinsIBA 07/2014

Therapy/Procedure

6	Therapeutics 01/2021 - 07/2014
2	Percutaneous Collagen Induction 11/2020 - 08/2020
2	Electrocoagulation (Electrocautery) 11/2020 - 08/2020
1	Tracheotomy 08/2022
1	Anesthesia 08/2022
1	Esophagectomy 08/2022
1	Low-Level Light Therapy (LLLT) 01/2017